Is a SUV cut-off necessary in the evaluation of the response of axillary lymph node metastases to neoadjuvant therapy?

Eur J Nucl Med Mol Imaging. 2010 Nov;37(11):2202. doi: 10.1007/s00259-010-1578-y. Epub 2010 Sep 7.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Biological Transport
  • Breast Neoplasms / diagnosis
  • Breast Neoplasms / metabolism
  • Breast Neoplasms / pathology*
  • Breast Neoplasms / therapy*
  • Fluorodeoxyglucose F18 / metabolism
  • Humans
  • Lymphatic Metastasis
  • Neoadjuvant Therapy*
  • Positron-Emission Tomography
  • Tomography, X-Ray Computed
  • Treatment Outcome

Substances

  • Fluorodeoxyglucose F18